Methyl-β-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 1, 2007, Pages 78-84

  Linder, A Elizabeth ^b   Thakali, Keshari M ^b   Thompson, Janice M ^b   Watts, Stephanie W ^b   Webb, R Clinton ^a   Leite, Romulo ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CHOLESTEROL; METHYL BETA CYCLODEXTRIN; PHENYLEPHRINE;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; DESENSITIZATION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SMOOTH MUSCLE FIBER; TACHYPHYLAXIS; VASCULAR RING;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BETA-CYCLODEXTRINS; CAVEOLIN 1; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; TACHYPHYLAXIS;

EID: 34548829702     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.123463     Document Type: Article

References (36)

1. Anderson KM, Murahashi T, Dostal DE, and Peach MJ (1993) Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol 264:C179-C188.
2. Anderson RG (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225.
3. Bari M, Battista N, Fezza F, Finazzi-Agro A, and Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280:12212-12220.
4. 125I]angiotensin II in norepinephrine-containing cells of the rat adrenal medulla. Endocrinology 119:1873-1875.
5. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472.
6. De Mey C and Vanhoutte PM (1981) Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney. Hypertension 3:718-724.
7. Feron O, Smith TW, Michel T, and Kelly RA (1997) Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272:17744-17748.
8. Fessart D, Simaan M, and Laporte SA (2005) c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin-mediated internalization. Mol Endocrinol 19:491-503.
9. Gáborik Z, Szaszak M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJ, and Hunyady L (2001) β-Arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59:239-247.
10. 2 receptors: imaging quantification by confocal microscopy. Synapse 61:231-241.
11. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, and Alexander RW (1986) Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 261:5901-5906.
12. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, and Schoepp DD (1988) Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol 146:85-95.
13. 2 receptor in caveolae. J Cell Sci 111:917-928.
14. Hardy G, Stanke-Labesque F, Peoc'h M, Hakim A, Devillier P, Caron F, Morel S, Faure P, Halimi S, and Bessard G (2001) Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats. Arterioscler Thromb Vasc Biol 21:1751-1758.
15. Hein L, Meinel L, Pratt RE, Dzau VJ, and Kobilka BK (1997) Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11:1266-1277.
16. Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ, and Thomas WG (2002) Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol Pharmacol 61:768-777.
17. Houndolo T, Boulay PL, and Claing A (2005) G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells. J Biol Chem 280:5598-5604.
18. 1 angiotensin receptor internalization. Regul Pept 91:29-44.
19. Ishizaka N, Griendling KK, Lassegue B, and Alexander RW (1998) Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-466.
20. Je HD, Gallant C, Leavis PC, and Morgan KG (2004) Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286:H91-H98.
21. Kaiser RA, Oxhorn BC, Andrews G, and Buxton IL (2002) Functional compartmentation of endothelial P2Y receptor signaling. Circ Res 91:292-299.
22. Kanashiro CA, Paiva TB, Paiva AC, Prioste RN, Aboulafia J, and Shimuta SI (1995) Angiotensin II tachyphylaxis in the guinea pig ileum and its prevention: a pharmacological and biochemical study. J Pharmacol Exp Ther 275:1543-1550.
23. Kule CE, Karoor V, Day JN, Thomas WG, Baker KM, Dinh D, Acker KA, and Booz GW (2004) Agonist-dependent internalization of the angiotensin II type one receptor (AT1): role of C-terminus phosphorylation in recruitment of beta-arrestins. Regul Pept 120:141-148.
24. Lázari MF, Porto CS, Freymuller E, Abreu LC, and Picarelli ZP (1997) Receptormediated endocytosis of angiotensin II in rat myometrial cells. Biochem Pharmacol 54:399-408.
25. Linder AE and Bendhack LM (2002) Endothelin-1-induced contraction is impaired in the tail artery of renal hypertensive rats. Vasc Pharmacol 39:77-82.
26. Linder AE, McCluskey LP, Cole KR 3rd, Lanning KM, and Webb RC (2005) Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta. J Pharmacol Exp Ther 314:9-15.
27. McGookey DJ, Fagerberg K, and Anderson RG (1983) Filipin-cholesterol complexes form in uncoated vesicle membrane derived from coated vesicles during receptor-mediated endocytosis of low density lipoprotein. J Cell Biol 96:1273-1278.
28. Motta SC, Poletti EF, Souza SE, Correa SA, Jubilut GN, Paiva AC, Shimuta SI, and Nakaie CR (2003) Tachyphylactic properties of angiotensin II analogs with bulky and hydrophobic substituents at the N-terminus. J Pept Res 62:227-232.
29. Robertson MJ, Wragg A, and Clark KL (1994) Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan. Regul Pept 50:137-145.
30. 2 alpha on angiotensin-induced contraction and tachyphylaxis in rat aortic rings. Pharmacol Toxicol 70:60-64.
31. Thomas WG (1999) Regulation of angiotensin II type 1 (AT1) receptor function. Regul Pept 79:9-23.
32. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, and Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251.
33. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW (2001) Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276:48269-48275.
34. Wyse BD, Prior IA, Qian H, Morrow IC, Nixon S, Muncke C, Kurzchalia TV, Thomas WG, Parton RG, and Hancock JF (2003) Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278:23738-23746.
35. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, and Navar LG (2002) Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39:116-121.
36. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, and Alexander RW (2005) Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25:1824-1830.